- 8 health systems with boosted outlooks
- Managing RCM Disruption with a Strong Patient Payments Strategy
- Why sports partnerships aren’t always home runs for health systems
- Employers are done being quiet about healthcare costs
- Justice Department reclassifies marijuana products: What it means for healthcare
- Southeast Health names CFO successor
- IR Centers, New Jersey Urology to open multiple outpatient centers
- UR Medicine rebrands
- Optum’s turnaround ahead of schedule: Execs
- Justice Department reclassifies marijuana products: What it means for healthcare
- Ozempic pill for children to launch in US market ‘soon’: Novo Nordisk
- Why dental practice owners are feeling a financial squeeze in 2026
- The region seeing a GI boom
- Atropos Health launches medical evidence library
- 5 ASC leaders building the multi-specialty platforms of the future
- Tenet exec pay by the numbers
- What the dental industry can learn from DSO restructurings
- Highest-paid payer CFOs in 2025
- 3 emerging challenges in dentistry
- The employment vs. independence pressure point
- Cincinnati Children’s appoints psychiatry division director
- What is psilocybin? Inside Trump’s push for psychedelic treatments
- Medical real estate developer breaks ground on $16M MOB
- Parkview Dental Partners continues Florida expansion
- What this ASC leader says is driving poor outcomes
- UnityPoint opens CRC clinic in Wisconsin
- ‘The margin quickly goes to zero’: Why cardiology ASC economics are so precarious
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Regeneron to unveil latest 'most favored nation' drug pricing deal with White House
- Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit
- FDA citizen petition calls on agency to tighten up CRL disclosure practices
- With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- Most Americans Worried About Brain Health, But Few Know How To Protect It
- CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
- ER Study Finds Major Gaps in Measles Immunity
- With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
- IVF 'Add On' Procedure Doesn't Work, Evidence Review Concludes
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- New Treatment Improves Survival for Aggressive Breast Cancer
- More than 60% of Americans using AI tools for medical information: survey
- Evonik to pump €80M into Slovakia production facility, add 50 jobs
- OpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacists
- Deerfield trots into pharma sales software space with CRM-enhancing tool
- Merck’s new AI commercial strategy ‘reimagining engagement with HCPs’
- ‘It buys patients time’: GLP-1s show early promise in addiction treatment
- North American Dental Group appoints vice president of education, development
- Maryland dental assistant sentenced for illegal opioid distribution
- South Carolina bills looks to ban mail-order orthodontics
- Care New England rolls out Butler Behavioral Health brand
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Grand Canyon University to add 6,000 to behavioral health pipeline
- AMA urges federal oversight of mental health chatbots
- Dental supplier lays off staff after large fire destroys business
- Recovery Unplugged expands virtual outpatient behavioral care to Pennsylvania
- 8 million Americans used psilocybin in past year: Study
- Heartland Dental to open Illinois office
- Novant Health, Amae partner on Charlotte behavioral health expansion
- Conservative think tank Paragon Health calls its shots on hospital policy reform
- North Carolina proposes 47% dental Medicaid reimbursement increase
- Amazon One Medical launches GLP-1 program integrated with primary care
- CDC Report on COVID Vaccine Blocked From Publication
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- RFK Jr. continues congressional hearing appearances to talk White House budget plan
- RFK Jr. Won't Commit to CDC Nominee's Vaccine Decisions
- Pentagon Drops Flu Vaccine Requirement For U.S. Military
- AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
- Zocdoc partners with Yelp to allow real-time scheduling
- CMS delays Part D GLP-1 model amid skepticism from insurers
- CMS delays Part D GLP-1 model amid skepticism from insurers
- Amneal seizes 'golden era' for biosims with $1.1B Kashiv buyout
- Samsung Biologics posts massive revenue growth as labor union rally sets strike in motion
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
- Male Infertility Linked To Cancer Risk
- Video Game Training Sharpens ER Doctors’ Split-Second Decisions
- Hidden Belly Fat Linked to Bladder Control in Women
- Mind-Controlled Bionic Suit Lets Paralyzed Patients Feel Every Step
- Napping Linked To Higher Risk Of Death Among Seniors, Study Finds
- Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
- Oak HC/FT backs Courier Health's $50M series B to build out AI for the biopharma patient experience
- Elevance Health seeing shift to bronze tier in ACA plans
- Novartis launches ‘Sjöut for Sjögren’s campaign, teams with Carrie Ann Inaba
- Community Health Systems attributes Q1 volumes stumble to consumers' macroeconomic fears, payers' prior auth denials
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- Merger to create nation's largest suicide prevention nonprofit
- Oz previews new plan to push states toward revalidating Medicaid providers
- Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
- Covera Health, Medmo combine to create end-to-end diagnostic imaging platform
- The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
- In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
- UnitedHealth Group spotlights AI investments as part of operational turnaround
- ECRI spins out healthcare supply chain division into Staritas, backed by PE firm Accel-KKR
- UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts
- Replimune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- 'Hospitals adverse to transparency'—clashing industry groups spar on mulligan 340B rebate pilot
- Amperos Health secures $16M in series A funding, unveils AI-native denial management solution
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- A look inside Highmark and Spring Health's mental well-being partnership
- CVS, Mass General Brigham primary care deal would increase annual care spending by $40M, report predicts
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Why UnitedHealth Group is betting big on doulas
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions
- Baby Food Recalled After Rat Poison Discovered in Jar
- Report Finds Drug Prices Rising Despite Trump Pricing Deals
- Trump Backs Psychedelic Research
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
- Physician burnout falls for third year in 2025 to 42%, AMA data shows
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says
- Dreams Affect Your Morning Mood In Surprising Ways, Study Finds
- Weed Blunts Brain Development In Teens
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Roche’s Enspryng cuts relapse risk by 68% in rare neuroinflammatory disease
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
The Doctor Patient Forum is requesting public support for FDA regulation of NarxCare by May 10, 2025. They explain and link the FDA comment page in their YouTube video (2 min):
Flagged. Medically Abandoned. Forgotten. Unveiling NarxCare: The Hidden Scoring System in Your EHR.
Unfortunately, DPF's assumption of big government to the rescue fails the logic test. Federal regulation to solve state overreach is a non-starter, but there is a better way.
The State of Michigan directly added the Michigan Automated Prescription System (MAPS) into the electronic health records (EHRs) and pharmacy management systems of hospitals, physician groups and pharmacies across the state in 2017, according to owner Appriss press release and State of Michigan sources. Lt. Gov. Brian Calley signed the enabling bill into law.
That MAPS package included NarxCare.
It is administered by LARA, but don't forget - it began with state legislators, and can only end the same way.
Both parties in Lansing have been operating on the progressive philosophy that "When the government knows and controls, we have better health." Nothing could be further from the truth, as we ought to have learned from COVID.
However, the Doctor Patient Forum's strength is understanding patient impact of status quo Michigan law, and public awareness is the best way to correct law.
I highly recommend their insights into state prescription drug tracing and patient pain control.
https://www.painnewsnetwork.org/stories/2018/5/19/what-every-patient-should-know-about-narxcare
What Every Patient Should Know About NarxCare
May 19, 2018
Walmart and Sam’s Club recently announced that by the end of August their pharmacists will start using NarxCare, a prescription tracking tool that analyzes real-time data about opioids and other controlled substances from Prescription Drug Monitoring Programs (PDMP’s).
Recent studies question the value of PDMP’s, but 49 states have implemented them so that physicians, pharmacists and insurers can see a patient's medication history. Granted, there is a need for monitoring the select few who doctor shop and/or abuse their medications, albeit that number is only in the 2 percent range.
What is NarxCare? Appriss Health developed NarxCare as a “robust analytics tool” to help “care teams” (doctors, pharmacists, etc.) identify patients with substance use disorders. Each patient is evaluated and given a “risk score” based on their prescription drug history. According to Appriss, a patient is much more willing to discuss their substance abuse issues once they are red flagged as a possible abuser.
“NarxCare automatically analyzes PDMP data and a patient’s health history and provides patient risk scores and an interactive visualization of usage patterns to help identify potential risk factors,” the company says on its website.
“NarxCare aids care teams in clinical decision making, provides support to help prevent or manage substance use disorder, and empowers states with the comprehensive platform they need to take to the next step in the battle against prescription drug addiction."
Sounds great doesn't it? Except prescription drugs are not the problem and never really have been. Illicit drug use has, is, and will continue to be the main cause of the addiction and overdose crisis.
Even the name NarxCare has a negative connotation. “Narx” stands for narcotics. And in today's environment, narcotics is a very negative word. NarxCare makes me feel like a narcotics police officer is just around the corner.
Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history.
Ohio, Michigan, Indiana, Iowa, and several other states are using NarxCare to supplement their own PDMPs. And Walmart isn’t the only big retail company to adopt it. Kroger, Ralphs, Kmart, CVS, Rite Aid and Walgreens are already using NarxCare. There’s a good chance your prescriptions are already being tracked by NarxCare and you don’t even know it.
But NarxCare doesn’t just analyze opioid prescriptions. It also tracks other controlled substances, such as antidepressants, sedatives and stimulants. If a patient is on any combination of those drugs, their risk scores and their chances of being red flagged will be higher – even if they’ve been safely taking the medications for years.
There are several other ways a patient can be red flagged, such as having multiple doctors or pharmacies. But what if you moved and changed physicians? What if you had the same physician for many years and he/she retired or moved away? What if your pharmacy refused to fill your prescription and you had to go pharmacy hunting every month? What if you had dental surgery and your dentist placed you on a short-term pain medication?
Unfortunately, the NarxCare scores do not reflect any of that. How can raw data on prescription medications be an indicator of abuse? I believe there is some merit in tracking and weeding out the rare abuser, but NarxCare doesn't factor in all the “what if’s” that can happen to law-abiding and responsible patients.
As pain patients, we need to be acutely aware of the negative impact this analytics tool can have. Many of us have already been required to sign pain contracts, take drugs tests, and undergo pill counts. In 2019, Medicare will adopt policies making it even harder for patients to get high doses of opioid medication. Some insurers are already doing it. We're already being policed enough as it is.
I intend to ask my physician, pharmacist and case manager if they utilize NarxCare. So should you. If they say yes, ask them why. Ask your doctor if they believe you are at risk for substance use disorder. Why is their judgement and treatment of you being second guessed by anyone?
Rochelle Odell lives in California. She’s lived for nearly 25 years with Complex Regional Pain Syndrome (CRPS/RSD).
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





